.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
Mallinckrodt
Boehringer Ingelheim
Novartis
McKinsey
Argus Health
Express Scripts
Colorcon
Cipla

Generated: June 24, 2017

DrugPatentWatch Database Preview

OXSORALEN-ULTRA Drug Profile

« Back to Dashboard

Which patents cover Oxsoralen-ultra, and what generic Oxsoralen-ultra alternatives are available?

Oxsoralen-ultra is a drug marketed by Dow Pharm and is included in one NDA.

The generic ingredient in OXSORALEN-ULTRA is methoxsalen. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.

Summary for Tradename: OXSORALEN-ULTRA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list93
Clinical Trials: see list232
Patent Applications: see list3,090
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXSORALEN-ULTRA at DailyMed

Pharmacology for Tradename: OXSORALEN-ULTRA

Ingredient-typePsoralens
Drug ClassPhotoactivated Radical Generator
Psoralen
Mechanism of ActionPhotoabsorption
Physiological EffectPhotosensitizing Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dow Pharm
OXSORALEN-ULTRA
methoxsalen
CAPSULE;ORAL019600-001Oct 30, 1986ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: OXSORALEN-ULTRA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dow Pharm
OXSORALEN-ULTRA
methoxsalen
CAPSULE;ORAL019600-001Oct 30, 19864,454,152► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Fuji
Colorcon
Teva
McKesson
Federal Trade Commission
Daiichi Sankyo
Healthtrust
McKinsey
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot